BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, van Loon AM, Frassoni F, Bacigalupo A, Schaefer UW, Osterhaus AD, Gratama JW, Löwenberg B, Verdonck LF, Cornelissen JJ. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood 2001;98:972-8. [PMID: 11493441 DOI: 10.1182/blood.v98.4.972] [Cited by in Crossref: 267] [Cited by in F6Publishing: 74] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Peres E, Savasan S, Klein J, Abidi M, Dansey R, Abella E. High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens. J Clin Microbiol 2005;43:3540-3. [PMID: 16000501 DOI: 10.1128/JCM.43.7.3540-3543.2005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Stauch D, Dernier A, Sarmiento Marchese E, Kunert K, Volk HD, Pratschke J, Kotsch K. Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity. PLoS One 2009;4:e4709. [PMID: 19266059 DOI: 10.1371/journal.pone.0004709] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
3 Wu HL, Weber WC, Shriver-Munsch C, Swanson T, Northrup M, Price H, Armantrout K, Robertson-LeVay M, Reed JS, Bateman KB, Mahyari E, Thomas A, Junell SL, Hobbs TR, Martin LD, MacAllister R, Bimber BN, Slifka MK, Legasse AW, Moats C, Axthelm MK, Smedley J, Lewis AD, Colgin L, Meyers G, Maziarz RT, Burwitz BJ, Stanton JJ, Sacha JB. Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications. Xenotransplantation 2020;27:e12578. [PMID: 31930750 DOI: 10.1111/xen.12578] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cohen JI. Vaccine Development for Epstein-Barr Virus. Adv Exp Med Biol 2018;1045:477-93. [PMID: 29896681 DOI: 10.1007/978-981-10-7230-7_22] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
5 Cohen JI. Epstein-barr virus vaccines. Clin Transl Immunology. 2015;4:e32. [PMID: 25671130 DOI: 10.1038/cti.2014.27] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 13.6] [Reference Citation Analysis]
6 Heslop HE. How I treat EBV lymphoproliferation. Blood 2009;114:4002-8. [PMID: 19724053 DOI: 10.1182/blood-2009-07-143545] [Cited by in Crossref: 206] [Cited by in F6Publishing: 180] [Article Influence: 15.8] [Reference Citation Analysis]
7 Kinzel M, Dowhan M, Kalra A, Williamson TS, Dabas R, Jamani K, Chaudhry A, Shafey M, Jimenez-Zepeda V, Duggan P, Daly A, Dharmani-Khan P, Khan F, Storek J. Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation. Transplant Cell Ther 2021:S2666-6367(21)01263-X. [PMID: 34607072 DOI: 10.1016/j.jtct.2021.09.021] [Reference Citation Analysis]
8 Takahashi T, Maruyama Y, Saitoh M, Itoh H, Yoshimoto M, Tsujisaki M. Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A. Case Rep Hematol 2015;2015:926874. [PMID: 26425376 DOI: 10.1155/2015/926874] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Greijer AE, Stevens SJ, Verkuijlen SA, Juwana H, Fleig SC, Verschuuren EA, Hepkema BG, Cornelissen JJ, Brooimans RA, Verdonck LF, Middeldorp JM. Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients. Clin Dev Immunol 2012;2012:543085. [PMID: 23346186 DOI: 10.1155/2012/543085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
10 Compagno F, Basso S, Panigari A, Bagnarino J, Stoppini L, Maiello A, Mina T, Zelini P, Perotti C, Baldanti F, Zecca M, Comoli P. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives. Front Immunol 2020;11:567020. [PMID: 33042147 DOI: 10.3389/fimmu.2020.567020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Mehta RS, Saliba RM, Chen J, Rondon G, Hammerstrom AE, Alousi A, Qazilbash M, Bashir Q, Ahmed S, Popat U, Hosing C, Khouri I, Shpall EJ, Champlin RE, Ciurea SO. Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation. Br J Haematol 2016;173:444-55. [PMID: 26947769 DOI: 10.1111/bjh.13977] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
12 Yeh AC, O'Donnell PV, Schoch G, Martin PJ, McFarland C, McCune JS, Cooper JP, Doney K, Flowers MED, Sorror ML, Appelbaum FR, Storer BE, Gooley T, Deeg HJ. Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin. Bone Marrow Transplant 2021. [PMID: 34741096 DOI: 10.1038/s41409-021-01518-0] [Reference Citation Analysis]
13 van Bergen CA, van Luxemburg-Heijs SA, de Wreede LC, Eefting M, von dem Borne PA, van Balen P, Heemskerk MH, Mulder A, Claas FH, Navarrete MA, Honders WM, Rutten CE, Veelken H, Jedema I, Halkes CJ, Griffioen M, Falkenburg JH. Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response. J Clin Invest 2017;127:517-29. [PMID: 28067665 DOI: 10.1172/JCI86175] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
14 Niemeyer BF, Oko LM, Medina EM, Oldenburg DG, White DW, Cool CD, Clambey ET, van Dyk LF. Host Tumor Suppressor p18INK4c Functions as a Potent Cell-Intrinsic Inhibitor of Murine Gammaherpesvirus 68 Reactivation and Pathogenesis. J Virol 2018;92:e01604-17. [PMID: 29298882 DOI: 10.1128/JVI.01604-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
15 Santos CAQ, Rhee Y, Czapka MT, Kazi AS, Proia LA. Make Sure You Have a Safety Net: Updates in the Prevention and Management of Infectious Complications in Stem Cell Transplant Recipients. J Clin Med 2020;9:E865. [PMID: 32245201 DOI: 10.3390/jcm9030865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hayden RT, Caliendo AM. Persistent Challenges of Interassay Variability in Transplant Viral Load Testing. J Clin Microbiol 2020;58:e00782-20. [PMID: 32554479 DOI: 10.1128/JCM.00782-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Odumade OA, Hogquist KA, Balfour HH. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24:193-209. [PMID: 21233512 DOI: 10.1128/cmr.00044-10] [Cited by in Crossref: 206] [Cited by in F6Publishing: 86] [Article Influence: 18.7] [Reference Citation Analysis]
18 Burns DM, Tierney R, Shannon-Lowe C, Croudace J, Inman C, Abbotts B, Nagra S, Fox CP, Chaganti S, Craddock CF, Moss P, Rickinson AB, Rowe M, Bell AI. Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event. Blood 2015;126:2665-75. [PMID: 26450987 DOI: 10.1182/blood-2015-08-665000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
19 Reddy N, Rezvani K, Barrett AJ, Savani BN. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol Blood Marrow Transplant 2011;17:591-7. [PMID: 20732435 DOI: 10.1016/j.bbmt.2010.08.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
20 Gui RR, Zu YL, Zhang Y, Han LJ, Zhao HF, Li Z, Yu FK, Wang J, Zhao JJ, Fu YW, Song YP, Zhou J. [Successful treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocytes infusion: three cases report and literatures review]. Zhonghua Xue Ye Xue Za Zhi 2019;40:333-5. [PMID: 31104448 DOI: 10.3760/cma.j.issn.0253-2727.2019.04.014] [Reference Citation Analysis]
21 Hill ER, Koganti S, Zhi J, Megyola C, Freeman AF, Palendira U, Tangye SG, Farrell PJ, Bhaduri-McIntosh S. Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes. J Virol 2013;87:11438-46. [PMID: 23966384 DOI: 10.1128/JVI.01762-13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
22 Zhang P, Zeng C, Cheng J, Zhou J, Gu J, Mao X, Zhang W, Cao Y, Luo H, Xu B, Li Q, Xiao M, Zhou J. Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases. Open Forum Infect Dis 2019;6:ofz171. [PMID: 31065564 DOI: 10.1093/ofid/ofz171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Gequelin LC, Riediger IN, Nakatani SM, Biondo AW, Bonfim CM. Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant. Rev Bras Hematol Hemoter 2011;33:383-8. [PMID: 23049344 DOI: 10.5581/1516-8484.20110103] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
24 Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA, Wagner JE. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood. 2006;108:2874-2880. [PMID: 16804113 DOI: 10.1182/blood-2006-03-011791] [Cited by in Crossref: 212] [Cited by in F6Publishing: 179] [Article Influence: 13.3] [Reference Citation Analysis]
25 Frey TR, Brathwaite J, Li X, Burgula S, Akinyemi IA, Agarwal S, Burton EM, Ljungman M, McIntosh MT, Bhaduri-McIntosh S. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus. J Virol 2020;94:e01966-19. [PMID: 31941784 DOI: 10.1128/JVI.01966-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Bitan M. Paving the way toward a better understanding of viral T cell interactions after stem cell transplantation. Clin Infect Dis 2006;42:1749-50. [PMID: 16705582 DOI: 10.1086/503846] [Reference Citation Analysis]
27 Li X, Akinyemi IA, You JK, Rezaei MA, Li C, McIntosh MT, Del Poeta M, Bhaduri-McIntosh S. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents. J Virol 2020;94:e01179-20. [PMID: 32796077 DOI: 10.1128/JVI.01179-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Han SB, Bae EY, Lee JW, Jang PS, Lee DG, Chung NG, Jeong DC, Cho B, Lee SJ, Kang JH, Kim HK. Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus. Int J Hematol 2014;100:188-99. [PMID: 24981711 DOI: 10.1007/s12185-014-1613-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ivana T, Robert P, Pavel S, Lenka T, Irena K. Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells. Transpl Immunol 2022;:101539. [PMID: 35051589 DOI: 10.1016/j.trim.2022.101539] [Reference Citation Analysis]
30 Chiusolo P, Metafuni E, Cattani P, Piccirillo N, Santangelo R, Manzara S, Bellesi S, De Michele T, Leone G, Sica S. Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. J Clin Immunol 2010;30:894-902. [PMID: 20737201 DOI: 10.1007/s10875-010-9454-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
31 Buelow D, Sun Y, Tang L, Gu Z, Pounds S, Hayden R. Comparative Evaluation of Four Real-Time PCR Methods for the Quantitative Detection of Epstein-Barr Virus from Whole Blood Specimens. J Mol Diagn 2016;18:527-34. [PMID: 27157323 DOI: 10.1016/j.jmoldx.2016.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
32 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
33 Burton EM, Goldbach-Mansky R, Bhaduri-McIntosh S. A promiscuous inflammasome sparks replication of a common tumor virus. Proc Natl Acad Sci U S A 2020;117:1722-30. [PMID: 31919284 DOI: 10.1073/pnas.1919133117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
34 Sica S, Metafuni E, Bellesi S, Chiusolo P. Epstein-barr virus related lymphoproliferations after stem cell transplantation. Mediterr J Hematol Infect Dis 2009;1:e2009019. [PMID: 21416005 DOI: 10.4084/MJHID.2009.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Rouce RH, Louis CU, Heslop HE. Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant. Curr Opin Hematol. 2014;21:476-481. [PMID: 25159713 DOI: 10.1097/moh.0000000000000083] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
36 Pratesi C, Zanussi S, Tedeschi R, Bortolin MT, Talamini R, Rupolo M, Scaini C, Basaglia G, Di Maso M, Mazzucato M, Zanet E, Tirelli U, Michieli M, Carbone A, De Paoli P. γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation. PLoS One 2015;10:e0116887. [PMID: 25668032 DOI: 10.1371/journal.pone.0116887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Dunmire SK, Odumade OA, Porter JL, Reyes-Genere J, Schmeling DO, Bilgic H, Fan D, Baechler EC, Balfour HH Jr, Hogquist KA. Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes. PLoS One 2014;9:e85422. [PMID: 24465555 DOI: 10.1371/journal.pone.0085422] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
38 Lam GY, Halloran BP, Peters AC, Fedorak RN. Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders. World J Gastrointest Pathophysiol 2015; 6(4): 181-192 [PMID: 26600976 DOI: 10.4291/wjgp.v6.i4.181] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
39 de Melo Silva J, Pinheiro-Silva R, Dhyani A, Pontes GS. Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases. Biomed Res Int 2020;2020:1627824. [PMID: 33163531 DOI: 10.1155/2020/1627824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Cao P, Zhang M, Wang L, Sai B, Tang J, Luo Z, Shuai C, Zhang L, Li Z, Wang Y, Li G, Xiang J. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas. BMC Cancer 2018;18:1293. [PMID: 30594162 DOI: 10.1186/s12885-018-5205-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
41 Ru Y, Zhang X, Song T, Ding Y, Zhu Z, Fan Y, Xu Y, Sun A, Qiu H, Jin Z, Tang X, Han Y, Fu Z, Chen S, Ma X, Chen F, Chen J, Wu D. Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes. Bone Marrow Transplant 2020;55:1754-62. [PMID: 32066862 DOI: 10.1038/s41409-020-0831-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
42 Yu S, Fan Q, Sun J, Fan Z, Zhang Y, Jiang Q, Huang F, Xuan L, Dai M, Zhou H, Liu H, Liu QF. Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia. Medicine (Baltimore) 2016;95:e2973. [PMID: 26986108 DOI: 10.1097/MD.0000000000002973] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
43 Watzinger F, Suda M, Preuner S, Baumgartinger R, Ebner K, Baskova L, Niesters HG, Lawitschka A, Lion T. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol. 2004;42:5189-5198. [PMID: 15528714 DOI: 10.1128/jcm.42.11.5189-5198.2004] [Cited by in Crossref: 200] [Cited by in F6Publishing: 97] [Article Influence: 11.8] [Reference Citation Analysis]
44 Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol 2013;6:94. [PMID: 24341630 DOI: 10.1186/1756-8722-6-94] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
45 Debaugnies F, Busson L, Ferster A, Lewalle P, Azzi N, Aoun M, Verhaegen G, Mahadeb B, de Marchin J, Vandenberg O, Hallin M. Detection of Herpesviridae in whole blood by multiplex PCR DNA-based microarray analysis after hematopoietic stem cell transplantation. J Clin Microbiol 2014;52:2552-6. [PMID: 24829249 DOI: 10.1128/JCM.00061-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
46 Goodyer M, Sargent J, Bond J, McMahon C, Dunne B, Smith O. Allogeneic stem cell transplantation as immunotherapy for X-linked lymphoproliferative disease-associated cerebral T-cell lymphoma. Br J Haematol 2013;163:133-5. [PMID: 23829589 DOI: 10.1111/bjh.12454] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Liu H, Zheng X, Zhang C, Xie J, Gao B, Shao J, Yang Y, Wang H, Yan J. Outcomes of haploidentical bone marrow transplantation in patients with severe aplastic anemia-II that progressed from non-severe acquired aplastic anemia. Front Med 2021. [PMID: 34170455 DOI: 10.1007/s11684-020-0807-4] [Reference Citation Analysis]
48 Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. Biol Blood Marrow Transplant 2009;15:1609-19. [PMID: 19744572 DOI: 10.1016/j.bbmt.2009.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
49 Gulley ML, Tang W. Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev. 2010;23:350-366. [PMID: 20375356 DOI: 10.1128/cmr.00006-09] [Cited by in Crossref: 157] [Cited by in F6Publishing: 52] [Article Influence: 13.1] [Reference Citation Analysis]
50 Sugimoto-Sekiguchi H, Tashiro H, Shirasaki R, Arai T, Yamamoto T, Oka Y, Akiyama N, Kawasugi K, Shirafuji N. Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia. Case Rep Gastrointest Med 2012;2012:395801. [PMID: 23050175 DOI: 10.1155/2012/395801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Gross TG. Is an ounce of prevention worth a pound of cure? Pediatr Blood Cancer 2006;47:117-8. [PMID: 16276525 DOI: 10.1002/pbc.20670] [Reference Citation Analysis]
52 Mohty M, Bacigalupo A, Saliba F, Zuckermann A, Morelon E, Lebranchu Y. New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity. Drugs 2014;74:1605-34. [PMID: 25164240 DOI: 10.1007/s40265-014-0277-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
53 Luderer R, Kok M, Niesters HG, Schuurman R, de Weerdt O, Thijsen SF. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation. Mol Diagn. 2005;9:195-200. [PMID: 16392898 DOI: 10.2165/00066982-200509040-00005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
54 Bacigalupo A. Alternative donor transplants for severe aplastic anemia. Hematology Am Soc Hematol Educ Program 2018;2018:467-73. [PMID: 30504347 DOI: 10.1182/asheducation-2018.1.467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
55 van Langelaar J, Wierenga-Wolf AF, Samijn JPA, Luijks CJM, Siepman TA, van Doorn PA, Bell A, van Zelm MC, Smolders J, van Luijn MM. The association of Epstein-Barr virus infection with CXCR3+ B-cell development in multiple sclerosis: impact of immunotherapies. Eur J Immunol 2021;51:626-33. [PMID: 33152118 DOI: 10.1002/eji.202048739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Yanir A, Yatsiv I, Braun J, Zilkha A, Brooks R, Bouhanna D, Weintraub M, Stepensky P. Rare complications after second hematopoietic stem cell transplantation for thalassemia major. J Pediatr Hematol Oncol 2012;34:e209-11. [PMID: 22395220 DOI: 10.1097/MPH.0b013e3182431c3c] [Reference Citation Analysis]
57 de Witte M, Daenen LGM, van der Wagen L, van Rhenen A, Raymakers R, Westinga K, Kuball J. Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and Adjust. Hemasphere 2021;5:e580. [PMID: 34095763 DOI: 10.1097/HS9.0000000000000580] [Reference Citation Analysis]
58 Kanakry JA, Kasamon YL, Bolaños-Meade J, Borrello IM, Brodsky RA, Fuchs EJ, Ghosh N, Gladstone DE, Gocke CD, Huff CA, Kanakry CG, Luznik L, Matsui W, Mogri HJ, Swinnen LJ, Symons HJ, Jones RJ, Ambinder RF. Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 2013;19:1514-7. [PMID: 23871780 DOI: 10.1016/j.bbmt.2013.07.013] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
59 Hickey CL, Romee R, Nikiforow S, Dorfman D, Mazzeo M, Koreth J. A case of Epstein Barr virus-related post-transplant lymphoproliferative disorder after haploidentical allogeneic stem cell transplantation using post-transplantation cyclophosphamide. Haematologica 2020;105:e379-81. [PMID: 32241847 DOI: 10.3324/haematol.2019.236067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Mashima K, Yano S, Yokoyama H, Saito T, Machishima T, Shimada T, Yahagi Y, Takahara S, Sugiyama K, Ogasawara Y, Minami J, Kamiyama Y, Katsube A, Suzuki K, Ohshima S, Yamada H, Usui N, Aiba K. Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review. Intern Med 2017;56:701-6. [PMID: 28321074 DOI: 10.2169/internalmedicine.56.7722] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
61 Pidala J, Tomblyn M, Nishihori T, Ayala E, Field T, Fernandez H, Perez L, Locke F, Alsina M, Ochoa JL, Perkins J, Tate C, Shapiro J, Conwell M, Bookout R, Anasetti C. ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011;17:1237-44. [PMID: 21215811 DOI: 10.1016/j.bbmt.2010.12.705] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
62 Irving WL. The role of the virology laboratory in the management of hepatitis C virus infection. J Clin Virol 2002;25:3-13. [PMID: 12126716 DOI: 10.1016/s1386-6532(02)00026-4] [Cited by in Crossref: 152] [Cited by in F6Publishing: 70] [Article Influence: 7.6] [Reference Citation Analysis]
63 Shaffer DR, Rooney CM, Gottschalk S. Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation. Immunotherapy 2010;2:663-71. [PMID: 20874650 DOI: 10.2217/imt.10.43] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
64 Naik S, Riches M, Hari P, Kim S, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Woo Ahn K, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT. Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study. Transpl Infect Dis 2019;21:e13145. [PMID: 31301099 DOI: 10.1111/tid.13145] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
65 Bao X, Zhu Q, Qiu H, Chen F, Xue S, Ma X, Sun A, Wu D. [Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2016;37:138-43. [PMID: 27014984 DOI: 10.3760/cma.j.issn.0253-2727.2016.02.011] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
66 Nam M, Shin S, Park KU, Kim I, Yoon SS, Kwon TK, Song EY. Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation. Ann Lab Med 2018;38:591-8. [PMID: 30027704 DOI: 10.3343/alm.2018.38.6.591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
67 Smith AR, Wagner JE. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol 2009;147:246-61. [PMID: 19796274 DOI: 10.1111/j.1365-2141.2009.07828.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
68 Hanaoka N, Murata S, Hosoi H, Shimokado A, Mushino T, Kuriyama K, Hatanaka K, Nishikawa A, Kurimoto M, Sonoki T, Muragaki Y, Nakakuma H. B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia. Hematol Rep 2015;7:5906. [PMID: 26487932 DOI: 10.4081/hr.2015.5906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
69 Enok Bonong PR, Zahreddine M, Buteau C, Duval M, Laporte L, Lacroix J, Alfieri C, Trottier H. Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis. Vaccines (Basel) 2021;9:288. [PMID: 33808928 DOI: 10.3390/vaccines9030288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Holman CJ, Karger AB, Mullan BD, Brundage RC, Balfour HH Jr. Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Clin Transplant 2012;26:741-7. [PMID: 22385033 DOI: 10.1111/j.1399-0012.2012.01608.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
71 Imafuku A, Tanaka K, Marui Y, Ubara Y, Takaichi K, Tomikawa S, Ota Y, Fujii T, Ishii Y. Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Diagnosed by Peripheral Facial Nerve Palsy. Intern Med 2018;57:1899-903. [PMID: 29434151 DOI: 10.2169/internalmedicine.9613-17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
72 Li Pira G, Di Cecca S, Biagini S, Girolami E, Cicchetti E, Bertaina V, Quintarelli C, Caruana I, Lucarelli B, Merli P, Pagliara D, Brescia LP, Bertaina A, Montanari M, Locatelli F. Preservation of Antigen-Specific Functions of αβ T Cells and B Cells Removed from Hematopoietic Stem Cell Transplants Suggests Their Use As an Alternative Cell Source for Advanced Manipulation and Adoptive Immunotherapy. Front Immunol 2017;8:332. [PMID: 28386262 DOI: 10.3389/fimmu.2017.00332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Luderer R, Kok M, Niesters HG, Schuurman R, de Weerdt O, Thijsen SF. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation. Mol Diagn. 2005;9:195-200. [PMID: 16392898 DOI: 10.1007/bf03260091] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
74 Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD; MATCH in PERSIMUNE study group. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. J Cancer Res Clin Oncol 2018;144:1569-80. [PMID: 29804164 DOI: 10.1007/s00432-018-2674-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
75 Mensen A, Na IK, Häfer R, Meerbach A, Schlecht M, Pietschmann ML, Gruhn B. Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD. J Cancer Res Clin Oncol 2014;140:1971-80. [PMID: 24962343 DOI: 10.1007/s00432-014-1742-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
76 Niesters HG. Molecular and diagnostic clinical virology in real time. Clin Microbiol Infect 2004;10:5-11. [PMID: 14706081 DOI: 10.1111/j.1469-0691.2004.00699.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 4.3] [Reference Citation Analysis]
77 Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, Valsamakis A. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127:2007-2017. [PMID: 26744460 DOI: 10.1182/blood-2015-09-672030] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 14.2] [Reference Citation Analysis]
78 Stoyanova EI, Riemens A, Lokhorst HM, te Boome L, Rothova A. Absence of intraocular infections after hematopoietic stem cell transplantation at a single center: the experience with current preventive regimens. Ocul Immunol Inflamm 2014;22:116-20. [PMID: 24102631 DOI: 10.3109/09273948.2013.827216] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Marinho-Dias J, Baldaque I, Pinho-Vaz C, Leite L, Branca R, Campilho F, Campos A Jr, Medeiros R, Sousa H. Association of Epstein‑Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal. Mol Med Rep 2019;19:1435-42. [PMID: 30592278 DOI: 10.3892/mmr.2018.9794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
80 Perandin F, Cariani E, Pollara CP, Manca N. Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma. BMC Microbiol 2007;7:22. [PMID: 17391518 DOI: 10.1186/1471-2180-7-22] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
81 Chen J, Wang X, He P, Li Y, Si M, Fan Z, Chang X, Xie Q, Jiao X. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis. J Med Virol 2016;88:541-9. [PMID: 26287378 DOI: 10.1002/jmv.24359] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
82 Yamaguchi J, Fujino T, Isa R, Nishiyama D, Kuwahara-Ota S, Kawaji Y, Tsukamoto T, Chinen Y, Shimura Y, Kobayashi T, Horiike S, Kohno K, Nakamura S, Kuroda J. Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia. Haematologica 2019;104:e376-9. [PMID: 30975907 DOI: 10.3324/haematol.2019.217141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]